Safety Study of FLP Injection to Treat Tumor Patients

NCT01361529 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: FLP,dose escalation,MTD

Sponsor

Acea Bio (Hangzhou) Co., Ltd.